| abstract |
Useful for treating obstructive or inflammatory airway diseases, particularly asthma and chronic obstructive pulmonary disease (COPD), which contain two or more active ingredients and have the desired fluidity and dispersibility of drug particles Provision of new formulations. A dry powder formulation for inhalation comprising spray-dried particles, and a formulation particle for use in the treatment of occlusive or inflammatory airway diseases, each particle being a pharmaceutically acceptable hydrophobic excipient A pharmaceutical composition having a core of a first active ingredient in a substantially crystalline form, coated with a layer of a second active ingredient in a substantially amorphous form dispersed in. [Selection figure] None |